How One Hematologist’s Curiosity Is Changing Care: Dr. Lauren Merz Redefines “Benign Ethnic Neutropenia”
Sindy Escobar Alvarez, Program Director for Medical Research at Doris Duke Foundation, posted on LinkedIn:
”Scientists take nagging questions, and through relentless pursuit of the answers, make discoveries that can change lives, including their own.
This trajectory is illustrated in a recent Medscape feature on hematologist Dr. Lauren Merz, whose curiosity about a condition flagged as “benign ethnic neutropenia” changed the course of her career. Despite the fact that this particular marker of a low neutrophil count has little clinical impact, it has kept patients out of clinical trials, made them ineligible for certain chemotherapies, and subjected others to needless invasive testing.
Dr. Merz, assistant professor at Rogel Cancer Center at the University of Michigan has led the DDF-supported work of the American Society of Hematology to develop new reference ranges for patients with the phenotype that causes this low neutrophil count, and test them nationwide.
Read the interview to see how her quick path from curiosity to action is changing medical understanding, and will improve patient care for millions.”
Stay updated with Hemostasis Today.
-
Sep 8, 2026, 11:15Andreas Tridimas: Atherosclerosis Is Greyer Than We Admit
-
Sep 8, 2026, 10:59Eman M. Elsabbagh: Pediatric Nonmalignant HCT Enters the Era of Precision Conditioning and Gene Therapy
-
Sep 8, 2026, 10:50Dena Winchester: Sponsored Genetic Testing Programs Improve Access for Children With Hemophilia A
-
Sep 8, 2026, 10:49Alessandra Bosch: Von Willebrand Disease and Rare Bleeding Disorders, Collaborative Insights and Patient Empowerment
-
Sep 8, 2026, 09:42Vineet Sankhla: Rethinking Potent P2Y12 Inhibition in AF Patients Undergoing PCI
-
Sep 8, 2026, 09:23Mehdi Mirsaeidi: Platelets and Thromboinflammation in COPD
-
Sep 8, 2026, 09:03Michel Cabrera Ortega: LAAC vs OAC – Which Risk Are We Trading?
-
Sep 8, 2026, 08:58Zehraan Ibni Akbar: Reading Blood Through the Peripheral Smear
-
Sep 8, 2026, 08:50Dirk Sibbing: Potent P2Y12 Inhibition in Patients With Atrial Fibrillation and Acute Coronary Syndrome